These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3815512)

  • 1. Anticoagulation with heparin during cardiac catheterization and its reversal by protamine.
    Dehmer GJ; Haagen D; Malloy CR; Schmitz JM
    Cathet Cardiovasc Diagn; 1987; 13(1):16-21. PubMed ID: 3815512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel protamine variant reversal of heparin anticoagulation in human blood in vitro.
    Hulin MS; Wakefield TW; Andrews PC; Wrobleski SK; Stoneham MD; Doyle AR; Zelenock GB; Jacobs LA; Shanley CJ; TenCate VM; Stanley JC
    J Vasc Surg; 1997 Dec; 26(6):1043-8. PubMed ID: 9423721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
    Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD
    J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombolysis After Protamine Reversal of Heparin for Acute Ischemic Stroke After Cardiac Catheterization: Case Report and Literature Review.
    Warner DS; Schwartz BG; Babygirija R; Rovin RA; Kassam AB; Biddick L; Sajjad R; Chohan A; Panichpisal K
    Neurologist; 2018 Nov; 23(6):194-196. PubMed ID: 30379743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of differing rates of protamine reversal of heparin anticoagulation.
    Wakefield TW; Hantler CB; Wrobleski SK; Crider BA; Stanley JC
    Surgery; 1996 Feb; 119(2):123-8. PubMed ID: 8571194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of heparin anticoagulation by recombinant platelet factor 4 in humans.
    Dehmer GJ; Fisher M; Tate DA; Teo S; Bonnem EM
    Circulation; 1995 Apr; 91(8):2188-94. PubMed ID: 7697848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextran sulfate included in factor Xa assay reagent overestimates heparin activity in patients after heparin reversal by protamine.
    Mouton C; Calderon J; Janvier G; Vergnes MC
    Thromb Res; 2003; 111(4-5):273-9. PubMed ID: 14693175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the hemodynamic and hematologic toxicity of a protamine variant after reversal of low-molecular-weight heparin anticoagulation in a canine model.
    Hulin MS; Wakefield TW; Andrews PC; Wrobleski SK; Kadell AM; Downing LJ; Stanley JC
    Lab Anim Sci; 1997 Apr; 47(2):153-60. PubMed ID: 9150494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic changes occurring with cardiac catheterization.
    Friedman HS; Trivelli LA; Nguyen T; Benamor R; Dorsa M
    Cathet Cardiovasc Diagn; 1988; 15(2):89-91. PubMed ID: 3180213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and toxicity of differently charged polycationic protamine-like peptides for heparin anticoagulation reversal.
    DeLucia A; Wakefield TW; Andrews PC; Nichol BJ; Kadell AM; Wrobleski SK; Downing LJ; Stanley JC
    J Vasc Surg; 1993 Jul; 18(1):49-58; discussion 58-60. PubMed ID: 8326659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
    Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
    ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteplase for Acute Ischemic Stroke after Heparin Reversal with Protamine: A Case Report and Review.
    Fontaine GV; Smith SM
    Pharmacotherapy; 2017 Oct; 37(10):e103-e106. PubMed ID: 28741720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients.
    Gale AJ; Elias DJ; Averell PM; Teirstein PS; Buck M; Brown SD; Polonskaya Z; Udit AK; Finn MG
    Thromb Res; 2011 Oct; 128(4):e9-13. PubMed ID: 21496885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of heparin resistance with Antithrombin III in cardiac surgery.
    Kanbak M
    Can J Anaesth; 1999 Jun; 46(6):581-5. PubMed ID: 10391608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin neutralization by recombinant platelet factor 4 and protamine.
    Levy JH; Cormack JG; Morales A
    Anesth Analg; 1995 Jul; 81(1):35-7. PubMed ID: 7598278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are the point-of-care diagnostics MULTIPLATE and ROTEM valid in the setting of high concentrations of heparin and its reversal with protamine?
    Gertler R; Wiesner G; Tassani-Prell P; Braun SL; Martin K
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):981-6. PubMed ID: 21315618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans.
    Dehmer GJ; Lange RA; Tate DA; Pirwitz M; Daniel W; Fisher M; Bonnem EM
    Circulation; 1996 Nov; 94(9 Suppl):II347-52. PubMed ID: 8901773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate effects of individualized heparin and protamine management on hemostatic activation and platelet function in adult patients undergoing cardiac surgery with tranexamic acid antifibrinolytic therapy.
    Hofmann B; Bushnaq H; Kraus FB; Raspé C; Simm A; Silber RE; Ludwig-Kraus B
    Perfusion; 2013 Sep; 28(5):412-8. PubMed ID: 23625867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.